Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.66 |
| ▸ | AR | P10275 | 17/20 | 0.64 |
| ▸ | GABRP | O00591 | 1/20 | 0.64 |
| ▸ | GABRD | O14764 | 1/20 | 0.64 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.64 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.64 |
| ▸ | PGR | P06401 | 1/20 | 0.64 |
| ▸ | KLK3 | P07288 | 1/20 | 0.64 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.64 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.64 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.64 |
| ▸ | CNR1 | P21554 | 1/20 | 0.64 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.64 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.64 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.64 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.64 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.64 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.64 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.64 |
| ▸ | GABRE | P78334 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10052134 | 0.90 | AR (0.62) | ABCG2ARGABRPGABRDNR1I2 | |
| SCHEMBL7033884 | 0.90 | AR (0.79) | ABCG2ARGABRPGABRDNR1I2 | |
| SCHEMBL23394340 | 0.90 | AR (0.68) | ABCG2ARGABRPGABRDNR1I2 | |
| SCHEMBL21788396 | 0.89 | ABCG2 (0.65) | ABCG2ARGABRPGABRDNR1I2 | |
| SCHEMBL18839004 | 0.89 | ABCG2 (0.62) | ABCG2ARGABRPGABRDNR1I2 | |
| SCHEMBL189993 | 0.88 | ABCG2 (0.85) | ABCG2ARGABRPGABRDNR1I2 | |
| SCHEMBL26158840 | 0.87 | AR (0.68) | ABCG2ARGABRPGABRDNR1I2 | |
| SCHEMBL15506558 | 0.87 | ABCG2 (0.58) | ABCG2ARGABRPGABRDNR1I2 | |
| SCHEMBL26276099 | 0.87 | ABCG2 (0.75) | ABCG2ARGABRPGABRDNR1I2 | |
| SCHEMBL18832260 | 0.86 | AR (0.67) | ABCG2ARGABRPGABRDNR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230158152-A1 | PROTEOLYSIS REGULATOR AND METHOD FOR USING SAME | MEDSHINE DISCOVERY INC. (CN) | 2023-05-25 | — | — | US | disclosed |
| WO-2017081702-A3 | A PROCESS FOR PREPARATION OF ENZALUTAMIDE | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2017-07-13 | — | — | WO | disclosed |
| WO-2017081702-A2 | A PROCESS FOR PREPARATION OF ENZALUTAMIDE | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2017-05-18 | — | — | WO | disclosed |
| US-20120035231-A1 | SPECIFIC DIARYLHYDANTOIN AND DIARYLTHIOHYDANTOIN COMPOUNDS | MEDIVATION PROSTATE THERAPEUTICS LLC | 2012-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230158152-A1 | PROTEOLYSIS REGULATOR AND METHOD FOR USING SAME | PSMA6, PSMC1, PSMA1 | ABCG2 4168/4885AR 1545/4885GABRP 1639/4885 |
| US-20120035231-A1 | SPECIFIC DIARYLHYDANTOIN AND DIARYLTHIOHYDANTOIN COMPOUNDS | BPHL, PARK7, APP | ABCG2 1388/4885AR 266/4885GABRP 4093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.